Parkside Financial Bank & Trust Has $4.03 Million Stock Position in Procter & Gamble Company (The) $PG

Parkside Financial Bank & Trust raised its stake in Procter & Gamble Company (The) (NYSE:PGFree Report) by 24.8% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,297 shares of the company’s stock after acquiring an additional 5,019 shares during the quarter. Parkside Financial Bank & Trust’s holdings in Procter & Gamble were worth $4,030,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of PG. Kingstone Capital Partners Texas LLC raised its position in Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Northern Trust Corp increased its stake in shares of Procter & Gamble by 0.8% in the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after buying an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD raised its position in shares of Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after acquiring an additional 2,466,308 shares during the last quarter. Goldman Sachs Group Inc. raised its position in shares of Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after acquiring an additional 583,629 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in shares of Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after acquiring an additional 1,018,865 shares during the period. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Stock Up 0.5%

Procter & Gamble stock opened at $146.90 on Friday. The firm has a market capitalization of $343.28 billion, a price-to-earnings ratio of 21.45, a PEG ratio of 3.87 and a beta of 0.36. The company’s 50 day simple moving average is $152.93 and its 200 day simple moving average is $157.16. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.71 and a quick ratio of 0.51. Procter & Gamble Company has a fifty-two week low of $144.46 and a fifty-two week high of $180.43.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.09. The company had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The business’s revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period last year, the business posted $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be issued a dividend of $1.0568 per share. The ex-dividend date is Friday, October 24th. This represents a $4.23 annualized dividend and a yield of 2.9%. Procter & Gamble’s payout ratio is currently 61.61%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Jon R. Moeller sold 40,119 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the sale, the chief executive officer directly owned 319,375 shares in the company, valued at $50,228,106.25. This represents a 11.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Shailesh Jejurikar sold 13,039 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $2,050,643.53. Following the sale, the chief operating officer directly owned 28,036 shares in the company, valued at approximately $4,409,221.72. This represents a 31.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 150,488 shares of company stock valued at $23,529,718. Insiders own 0.20% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently commented on PG shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a research report on Wednesday, October 8th. BNP Paribas Exane reduced their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. JPMorgan Chase & Co. boosted their price target on shares of Procter & Gamble from $163.00 to $165.00 and gave the stock a “neutral” rating in a research note on Monday, October 27th. Raymond James Financial cut their price objective on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. Finally, Evercore ISI reaffirmed an “in-line” rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Twelve analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $171.53.

Get Our Latest Research Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.